Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
Open-market buys, last 90 days
$1,681,140
in 2 filings
Open-market sales, last 90 days
$425,829
in 1 filing, $426K under 10b5-1 plans

Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-01-21 KENNEY CHRISTOPHER JOHN Chief Medical Officer Purchase +700 $28.81 $20K 700
2021-12-15 AZAB MOHAMMAD Director Exercise or conversion +3,086 $3.67 $11K 66,819
2021-12-15 AZAB MOHAMMAD Director Exercise or conversion · Stock Option (Right to Buy) −3,086 0
2021-12-08 PATOU GARY Director Exercise or conversion +2,057 $3.67 $8K 25,630
2021-12-08 PATOU GARY Director Exercise or conversion · Stock Option (Right to Buy) −2,057 0
2021-12-06 Von Seggern Christopher Chief Commercial Officer Purchase +4,000 $24.40 $98K 4,000
2021-11-15 PIMSTONE SIMON N. Director Sale −17,557 $31.33 $550K 210,186
2021-08-23 KENNEY CHRISTOPHER JOHN Chief Medical Officer Grant or award · Stock Option (Right to Buy) +150,000 150,000
2021-06-03 PATOU GARY Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-03 Svoronos Dawn Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-03 Machado Patrick Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-03 Hayden Michael R Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-03 GANNON STEVEN Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-03 AZAB MOHAMMAD Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-03 GAROFALO ELIZABETH A. Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2021-06-03 MORTIMER IAN PRESIDENT & CEO Grant or award · Stock Option (Right to Buy) +125,000 125,000
2021-06-03 AULIN SHERRY Chief Financial Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2021-05-28 ROBIN SHERRINGTON EVP, Strategy & Innovation Exercise or conversion +12,345 $3.76 $46K 29,141
2021-05-28 ROBIN SHERRINGTON EVP, Strategy & Innovation Shares withheld for taxes −2,024 $18.91 $38K 27,117
2021-05-28 ROBIN SHERRINGTON EVP, Strategy & Innovation Exercise or conversion +13,374 $3.85 $51K 40,491

Page 19 of 27 · 536 trades